Decision Making with Prostate Cancer: A Multiple-Objective Model with Uncertainty

Published Online:https://doi.org/10.1287/inte.1080.0406

References

  • Barry M. J., Mulley A. G., Fowler F. J., Wennberg J. E. Watchful waiting vs. immediate transurethral resection for symptomatic prostatism. The importance of patients' preferences. J. Amer. Medical Assoc. (1988) 259(20):3010–3017CrossrefGoogle Scholar
  • Bremner K. E., Chong C. A., Tomlinson G., Alibhai S. M., Krahn M. D. A review and meta-analysis of prostate cancer utilities. Medical Decision Making (2007) 27(3):288–298CrossrefGoogle Scholar
  • Carroll P. R., Carducci M. A., Zietman A. L., Rothaermel J. M. Report to the nation on prostate cancer: A guide for men and their families. (2005) . Retrieved August 8, 2007, http://www.prostatecancerfoundation.org/atf/cf/%7B705B3273-F2EF-4EF6-A653-E15C5D8BB6B1%7D/PCF-RTN-GUIDE.PDFGoogle Scholar
  • Catalona W. J., Ramos C. G., Carvalhal G. Contemporary results of anatomic radical prostatectomy. CA: Cancer J. Clinicians (1999) 49(5):282–296CrossrefGoogle Scholar
  • Catalona W. J., Carvalhal G. F., Mager D. E., Smith D. S. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J. Urology (1999) 162(2):433–438CrossrefGoogle Scholar
  • Charlson M. E., Pompei P., Ales K. L., McKenzie C. R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Diseases (1987) 40(5):373–383CrossrefGoogle Scholar
  • Coen J. J., Chung C. S., Shipley W. U., Zietmad A. L. Influence of follow-up bias on PSA failure after external beam radiotherapy for localized prostate cancer: Results from a 10-year cohort analysis. Internat. J. Radiation Oncology Biol. Phys. (2003) 57(3):621–628CrossrefGoogle Scholar
  • Dyer J. S., Sarin R. K. Measurable multiattribute value functions. Oper. Res. (1979) 27(4):810–822LinkGoogle Scholar
  • Eastham J. A., Kattan M. W., Rogers E., Goad J., Ohori M., Boone T., Scardino P. T. Risk factors for urinary incontinence after radical prostatectomy. J. Urology (1996) 156(5):1707–1713CrossrefGoogle Scholar
  • Elstein A. S. Clinical judgment: Psychological research and medical practice. Science (1976) 194(4266):696–700CrossrefGoogle Scholar
  • Gelblum D. Y., Potters L. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Internat. J. Radiation Oncology Biol. Phys. (2000) 48(1):119–124CrossrefGoogle Scholar
  • Han M., Partin A. W., Pound C. R., Epstein J. I., Walsh P. C. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urologic Clinics North Amer. (2001) 28(3):555–565CrossrefGoogle Scholar
  • Han M., Partin A. W., Zahurak M., Piantadosi S., Epstein J. I., Walsh P. C. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J. Urology (2003) 169(2):517–523CrossrefGoogle Scholar
  • Hazen G. B. Multiattribute structure for QALYs. Decision Anal. (2004) 1(4):205–216LinkGoogle Scholar
  • Holmberg L., Bill-Axelson A., Helgesen F., Salo J. O., Folmerz P., Häggman M., Andersson S. O., et al.Scandinavian Prostatic Cancer Group Study Number 4 A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. New England J. Medicine (2002) 347(11):781–789CrossrefGoogle Scholar
  • Johannes C. B., Araujo A. B., Feldman H. A., Derby C. A., Kleinman K. P., McKinlay J. B. Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts male aging study. J. Urology (2000) 163(2):460–463CrossrefGoogle Scholar
  • Keeney R. Multiplicative utility functions. Oper. Res. (1974) 22:22–34LinkGoogle Scholar
  • Keeney R. L., Raiffa H.Decisions with Multiple Objectives: Preferences and Value Trade-offs (1976) (John Wiley & Sons, New York) Google Scholar
  • Kuban D. A., Thames H. D., Levy L. B., Horwitz E. M., Kupelian P. A., Martinez A. A., Michalski J. M., et al. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Internat. J. Radiation Oncology Biol. Phys. (2003) 57(4):915–928CrossrefGoogle Scholar
  • Kupelian P. A., Potters L., Khuntia D., Ciezki J. P., Reddy C. A., Reuther A. M., Carlson T. P., Klein E. A. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Internat. J. Radiation Oncology Biol. Phys. (2004) 58(1):25–33CrossrefGoogle Scholar
  • Malmsten U. G., Milsom I., Molander U., Norlén L. J. Urinary incontinence and lower urinary tract symptoms: An epidemiological study of men aged 45 to 99 years. J. Urology (1997) 158(5):1733–1737CrossrefGoogle Scholar
  • McDonald C. J. Medical heuristics: The silent adjudicators of clinical practice. Ann. Internal Medicine (1996) 124(1):56–62CrossrefGoogle Scholar
  • Miyamoto J. M. Quality-adjusted life years (QALY) utility models under expected utility and rank dependent utility assumptions. J. Math. Psych. (1999) 43:201–237CrossrefGoogle Scholar
  • MSN Money Life expectancy calculator. (2008) . Retrieved March 6, 2008, http://moneycentral.msn.com/investor/calcs/n_expect/main.aspGoogle Scholar
  • Pliskin J. S., Shepard D. S., Weinstein M. C. Utility functions for life years and health status. Oper. Res. (1980) 28:206–224LinkGoogle Scholar
  • Potters L., Torre T., Fearn P. A., Leibel S. A., Kattan M. W. Potency after permanent prostate brachytherapy for localized prostate cancer. Internat. J. Radiation Oncology Biol. Phys. (2001) 50(5):1235–1242CrossrefGoogle Scholar
  • Roehl K. A., Han M., Ramos C. G., Antenor J. V., Catalona W. J. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results. J. Urology (2004) 172(3):910–914CrossrefGoogle Scholar
  • Schover L. R., Fouladi R. T., Warneke C. L., Neese L., Klein E. A., Zippe C., Kupelian P. A. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer (2002) 95(8):1773–1785CrossrefGoogle Scholar
  • Singh A., Zelefsky M. J., Raben A., Lombardi D., Leibel S. A. Combined 3-dimensional conformal radiotherapy and transperineal Pd-103 permanent implantation for patients with intermediate and unfavorable risk prostate cancer. Internat. J. Cancer (2000) 90(5):275–280CrossrefGoogle Scholar
  • Stock R. G., Kao J., Stone N. N. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J. Urology (2001) 165(2):436–439CrossrefGoogle Scholar
  • Torrance G. W., Feeny D. Utilities and quality-adjusted life years. Internat. J. Tech. Assessment Health Care (1989) 5:559–575CrossrefGoogle Scholar
  • United States Social Security Administration Period life table. (2007) . Retrieved March 11, 2008, http://www.ssa.gov/OACT/STATS/table4c6.htmlGoogle Scholar
  • Vicini F. A., Kestin L. L., Martinez A. A. The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. Internat. J. Radiation Oncology Biol. Phys. (1999) 45(3):553–561CrossrefGoogle Scholar
  • Zelefsky M. J., Hollister T., Raben A., Matthews S., Wallner K. E. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Internat. J. Radiation Oncology Biol. Phys. (2000) 47(5):1261–1266CrossrefGoogle Scholar
  • Zelefsky M. J., Fuks Z., Hunt M., Yamada Y., Marion C., Ling C. C., Amols H., Venkatraman E. S., Leibel S. A. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J. Urology (2001) 166(3):876–881CrossrefGoogle Scholar
  • Zelefsky M. J., Fuks Z., Hunt M., Yamada Y., Marion C., Ling C. C., Amols H., Venkatraman E. S., Leibel S. A. High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients. Internat. J. Radiation Oncology Biol. Phys. (2002) 53(5):1111–1116CrossrefGoogle Scholar
  • Zelefsky M. J., Wallner K. E., Ling C. C., Raben A., Hollister T., Wolfe T., Grann A., Gaudin P., Fuks Z., Leibel S. A. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J. Clinical Oncology (1999) 17(2):517–522CrossrefGoogle Scholar
INFORMS site uses cookies to store information on your computer. Some are essential to make our site work; Others help us improve the user experience. By using this site, you consent to the placement of these cookies. Please read our Privacy Statement to learn more.